Haemophilia A and haemophilia B: molecular insights

No abstract is available for this paper.

• Publication year

  2002

• Venue

  Molecular Pathology

• Publication date

  2002-02-01

• Fields of study

  Biology, Medicine, History

• Identifiers
  DOI 10.1136/mp.55.2.127PMID 11836440PMCID PMC1187163
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Human Evolution

  2019cited by this paper
• Factor IX

  2014cited by this paper
• A new MspI restriction fragment length polymorphism in the hemophilia B locus

  2004cited by this paper
• Methods in Molecular Medicine: Melanoma Techniques and Protocols

  2002cited by this paper
• Initial sequencing and analysis of the human genome

  2001cited by this paper
• Rapid Hemophilia A Molecular Diagnosis by a Simple DNA Sequencing Procedure: Identification of 14 Novel Mutations

  2001cited by this paper
• A mechanism for exon skipping caused by nonsense or missense mutations in BRCA1 and other genes

  2001cited by this paper
• The sequence of the human genome (abstract only)

  2001cited by this paper
• Involvement of low-density lipoprotein receptor-related protein (LRP) in the clearance of factor VIII in von Willebrand factor-deficient mice.

  2000cited by this paper
• Intracellular accumulation of factor VIII induced by missense mutations Arg593→Cys and Asn618→Ser explains cross‐reacting material‐reduced haemophilia A

  2000cited by this paper
• A new polymorphism in the human factor VIII gene: implications for linkage analysis in haemophilia A and for the evolution of int22h sequences

  2000cited by this paper
• Sequencing with microarray technology--a powerful new tool for molecular diagnostics.

  2000cited by this paper
• Absence of Correlation between X Chromosome Inactivation Pattern and Plasma Concentration of Factor VIII and Factor IX in Carriers of Haemophilia A and B

  2000cited by this paper
• Activation of factor IX zymogen results in exposure of a binding site for low-density lipoprotein receptor-related protein.

  2000cited by this paper
• Fast and Efficient Mutation Detection Method Using Multiplex PCR and Cycle Sequencing

  2000cited by this paper
• An Effective Route for the Isolation of Human Genetic Loci Exemplified Using the BglI Restriction Fragment Length Polymorphism of the Factor VIII Gene

  2000cited by this paper
• Relationship between Factor VIII Mutation Type and Inhibitor Development in a Cohort of Previously Untreated Patients Treated with Recombinant Factor VIII (Recombinate™)

  2000cited by this paper
• A novel cause of mild/moderate hemophilia A: mutations scattered in the factor VIII C1 domain reduce factor VIII binding to von Willebrand factor.

  2000cited by this paper
• Specific analysis of the intron 22 XbaI polymorphism of the human factor VIII gene using long‐distance PCR

  1999cited by this paper
• Region of Factor IXa Protease Domain that Interacts with Factor VIIIa: Analysis of Select Hemophilia B Mutants

  1999cited by this paper
• Role of activation of the coagulation factor VIII in interaction with vWf, phospholipid, and functioning within the factor Xase complex.

  1999cited by this paper
• Human evolution.

  1999cited by this paper
• Factor VIII-Factor IX Interactions: Molecular Sites Involved in Enzyme-Cofactor Complex Assembly

  1999cited by this paper
• Intron 22‐specific long PCR for the Xba I polymorphism in the factor VIII gene

  1999cited by this paper
• DNA chip technology ante portas

  1999cited by this paper
• Region of factor IXa protease domain that interacts with factor VIIIa: analysis of select hemophilia B mutants.

  1999cited by this paper
• The Light Chain of Factor VIII Comprises a Binding Site for Low Density Lipoprotein Receptor-related Protein*

  1999cited by this paper
• Molecular Biological Aspects of Inhibitor Development

  1999cited by this paper
• Some Factor VIII (FVIII) Inhibitors Recognise a FVIII Epitope(s) that Is Present only on FVIII-vWF Complexes

  1999cited by this paper
• Determination of ancestral alleles for human single-nucleotide polymorphisms using high-density oligonucleotide arrays

  1999cited by this paper
• Start of UK Confidential Haemophilia A Database: Analysis of 142 Patients by Solid Phase Fluorescent Chemical Cleavage of Mismatch

  1999cited by this paper
• Role of the Low Density Lipoprotein-related Protein Receptor in Mediation of Factor VIII Catabolism*

  1999cited by this paper
• Molecular genetics of coagulation factor VIII gene and haemophilia A

  1998cited by this paper
• Molecular diagnostics of 15 hemophilia A patients: Characterization of eight novel mutations in the factor VIII gene, two of which result in exon skipping

  1998cited by this paper
• Single-tube polymerase chain reaction for rapid diagnosis of the inversion hotspot of mutation in hemophilia A.

  1998cited by this paper
• The life cycle of coagulation factor VIII in view of its structure and function.

  1998cited by this paper
• Linkage analysis in haemophilia A: simultaneous genotyping of two polymorphisms of the human factor VIII gene using induced heteroduplex formation

  1998cited by this paper
• The context of human genetic evolution.

  1998cited by this paper
• Laboratory methods for the genetic diagnosis of bleeding disorders.

  1998cited by this paper
• Mutation databases on the Web.

  1998cited by this paper
• Small Deletion/Insertion Mutations within Poly-A Runs of the Factor VIII Gene Mitigate the Severe Haemophilia A Phenotype

  1998cited by this paper
• The genetic basis of inhibitor development in haemophilia A

  1998cited by this paper
• Variant of intron 22 inversions in the factor VIII gene in severe hemophilia A.

  1997cited by this paper
• Missense mutations at ALA‐10 in the factor IX propeptide: an insignificant variant in normal life but a decisive cause of bleeding during oral anticoagulant therapy

  1997cited by this paper
• Partial correction of a severe molecular defect in hemophilia A, because of errors during expression of the factor VIII gene.

  1997cited by this paper
• The Acidic Region of the Factor VIII Light Chain and the C2 Domain Together Form the High Affinity Binding Site for von Willebrand Factor*

  1997cited by this paper
• Interaction of Factor IXa with Factor VIIIa

  1997cited by this paper
• Prevalence of anti‐FVIII antibodies in severe haemophilia A patients with inversion of intron 22

  1997cited by this paper
• A molecular model for the triplicated A domains of human factor VIII based on the crystal structure of human ceruloplasmin.

  1997cited by this paper
• HLA Genotype of Patients with Severe Haemophilia A due to Intron 22 Inversion with and without Inhibitors of Factor VIII

  1997cited by this paper
• Further evidence for the importance of an androgen response element in the factor IX promoter

  1997cited by this paper
• HLA Class II Profile: A Weak Determinant of Factor VIII Inhibitor Development in Severe Haemophilia A

  1997cited by this paper
• A mutation in the propeptide of Factor IX leads to warfarin sensitivity by a novel mechanism.

  1996cited by this paper
• A −793 G to A transition in the factor IX gene promoter is polymorphic in the caucasian population

  1996cited by this paper
• The molecular basis of haemophilia A and B.

  1996cited by this paper
• A novel DNA inversion causing severe hemophilia A.

  1996cited by this paper
• Isolation of the human gamma-carboxylase and a gamma-carboxylase-associated protein from factor IX-expressing mammalian cells.

  1996cited by this paper
• A genetic view on the etiology of the inhibitor complication.

  1996cited by this paper
• Factor VIII gene inversions in severe hemophilia A: results of an international consortium study.

  1995cited by this paper
• Diagnosis of Hemophilia B Carriers Using Two Novel Dinucleotide Polymorphisms and Hha I RFLP of the Factor IX Gene in Japanese Subjects

  1995cited by this paper
• Microsatellite evolution — evidence for directionality and variation in rate between species

  1995cited by this paper
• Ultrarapid mutation detection by multiplex, solid-phase chemical cleavage.

  1995cited by this paper
• X-ray structure of clotting factor IXa: active site and module structure related to Xase activity and hemophilia B.

  1995cited by this paper
• Investigation of the factor VIII intron 22 repeated region (int22h) and the associated inversion junctions.

  1995cited by this paper
• Molecular Genetics of Coagulation Factor VIII Gene and Hemophilia A

  1995cited by this paper
• Haemophilia A: Mutation Type Determines Risk of Inhibitor Formation

  1995cited by this paper
• Haemophilia A diagnosis by simultaneous analysis of two variable dinucleotide tandem repeats within the factor VIII gene

  1994cited by this paper
• “Cryptic” dinucleotide polymorphism in the 3′ region of the factor IX gene shows substantial variation among different populations

  1994cited by this paper
• Factor IX gene haplotypes in Brazilian Blacks and characterization of unusual Ddel alleles

  1994cited by this paper
• The role of amino-terminal residues of the heavy chain of factor IXa in the binding of its cofactor, factor VIIIa.

  1994cited by this paper
• First Report on UK Database of Haemophilia B Mutations and Pedigrees

  1994cited by this paper
• Inversions disrupting the factor VIII gene are a common cause of severe haemophilia A

  1993cited by this paper
• A Factor VIII Neutralizing Monoclonal Antibody and a Human Inhibitor Alloantibody Recognizing Epitopes in the C2 Domain Inhibit Factor VIII Binding to von Willebrand Factor and to Phosphatidylserine

  1993cited by this paper
• Characteristic mRNA abnormality found in half the patients with severe haemophilia A is due to large DNA inversions.

  1993cited by this paper
• Factor VIII Structure and Function

  1993cited by this paper
• Report of a joint WHO/WFH meeting on the control of haemophilia: carrier detection and prenatal diagnosis.

  1993cited by this paper
• An MseI RFLP in the 5’flanking region of the factor IX gene: its use for haemophilia B carrier detection in Caucasian and Thai populations

  1993cited by this paper
• Female Twins with Severe Christmas Disease (Hemophilia B)

  1993cited by this paper
• The skipping of constitutive exons in vivo induced by nonsense mutations

  1993cited by this paper
• Recovery from hemophilia B Leyden: an androgen-responsive element in the factor IX promoter.

  1992influential reference
• Sequence of the human factor VIII-associated gene is conserved in mouse.

  1992cited by this paper
• Identification and functional importance of tyrosine sulfate residues within recombinant factor VIII.

  1992cited by this paper
• Haplotype Analysis of Identical Factor IX Mutants Using PCR

  1992cited by this paper
• Hemophilia B caused by five different nondeletion mutations in the protease domain of factor IX.

  1992cited by this paper
• Evidence for a third transcript from the human factor VIII gene.

  1992cited by this paper
• von Willebrand Disease Masquerading as Haemophilia A

  1992cited by this paper
• Three Distinct Point Mutations in the Factor IX Gene of Three Japanese CRM+ Hemophilia B Patients (Factor IX BMNagoya 2, Factor IX Nagoya 3 and 4)

  1991cited by this paper
• Haemophilia B mutations in a complete Swedish population sample: a test of new strategy for the genetic counselling of diseases with high mutational heterogeneity

  1991cited by this paper
• Molecular characterization of severe hemophilia A suggests that about half the mutations are not within the coding regions and splice junctions of the factor VIII gene.

  1991cited by this paper
• Detection and characterisation of two missense mutations at a cleavage site in the factor VIII light chain.

  1991cited by this paper
• The varying frequencies of five DNA polymorphisms of X-linked coagulant factor IX in eight ethnic groups.

  1991cited by this paper
• Sulfation of Tyr1680 of human blood coagulation factor VIII is essential for the interaction of factor VIII with von Willebrand factor.

  1991cited by this paper
• Haemophilia A diagnosis by analysis of a hypervariable dinucleotide repeat within the factor VIII gene.

  1991cited by this paper
• Segments containing alternating purine and pyrimidine dinucleotides: patterns of polymorphism in humans and prevalence throughout phylogeny.

  1991cited by this paper
• Molecular characterization of mild-to-moderate hemophilia A: detection of the mutation in 25 of 29 patients by denaturing gradient gel electrophoresis.

  1991cited by this paper
• Detection of three novel mutations in two haemophilia A patients by rapid screening of whole essential region of factor VIII gene.

  1991cited by this paper
• Recurrent nonsense mutations at arginine residues cause severe hemophilia B in unrelated hemophiliacs

  1990cited by this paper
• Characterization of mutations in the factor VIII gene by direct sequencing of amplified genomic DNA.

  1990cited by this paper
• The incidence and distribution of CpG----TpG transitions in the coagulation factor IX gene. A fresh look at CpG mutational hotspots.

  1990cited by this paper
• A transcribed gene in an intron of the human factor VIII gene.

  1990cited by this paper

• Genetic Landscape and Linkage Analysis of Factor VIII Gene Markers in Indian Women: Improving Carrier Detection for Haemophilia A

  2026cites this paper
• Female football players’ key physical qualities: playing-position specific comparison between national-team selected and non-selected players

  2025cites this paper
• Factor IX and incident hypertension in Black and White adults: the REasons for Geographic and Racial Differences in Stroke cohort.

  2025cites this paper
• Relative age effect at Concacaf championships: Influence of sex, age, nationality, playing position, and playing status

  2025influential citation
• Language Modelling Techniques for Analysing the Impact of Human Genetic Variation

  2025cites this paper
• Debates Surrounding the Use of Antithrombotic Therapy in Hemophilic Patients with Cardiovascular Disease: Best Strategies to Minimize Severe Bleeding Risk

  2024cites this paper
• Genetic variant detection in a South African haemophilia B population

  2024cites this paper
• F8 Gene Splice Donor Mutation (c.1271+1G>A) in Individual with Mild Hemophilia A in Indonesia: A Case Study

  2024cites this paper
• Clinical Evaluation Of The Effect Of Tranexamic Acid Mouth Wash On Oral Health Status Of Hemophilic Children

  2024cites this paper
• Safe and effective liver-directed AAV-mediated homology-independent targeted integration in mouse models of inherited diseases

  2024cites this paper
• The role of protein corona on nanodrugs for organ-targeting and its prospects of application.

  2023cites this paper
• A basis for prenatal diagnosis of Haemophilia-A in Pakistani patients

  2022cites this paper
• Effect of prepropeptide replacement on γ-carboxylation and activity of recombinant coagulation factor IX

  2022cites this paper
• Recent advances in the production of recombinant factor IX: bioprocessing and cell engineering

  2022cites this paper
• Factor VIII companion diagnostic for haemophilia

  2022cites this paper
• Liver gene therapy with intein‐mediated F8 trans‐splicing corrects mouse haemophilia A

  2022cites this paper
• Defects of contact activation system (CAS) and kallikrein/kinin system (KKS)

  2022cites this paper
• Effect of prepropeptide replacement on gamma-carboxylation and activity of recombinant coagulation factor IX

  2022cites this paper
• Effect of CTLA-4 and TNF-α Gene Polymorphisms on Inhibitor Development in a Turkish Cohort of Severe Hemophilia A Cases with Intron 22 Inversion Mutation: An Analytical Study

  2022cites this paper
• Rare but not Abdicated: Status of Haemophilia in foothills of Himalaya, Uttarakhand: A cross-sectional study

  2021cites this paper
• Validation of a perioperative population factor VIII pharmacokinetic model with a large cohort of pediatric hemophilia a patients

  2021influential citation
• To find the correlation of the clinical findings with Hematological findings of bleeding disorders subjects

  2021cites this paper
• Molecular study of a large cohort of 109 haemophilia patients from Cuba using a gene panel with next generation sequencing‐based technology

  2021cites this paper
• Human coagulation factor IX: a systematic review of its characteristics

  2021cites this paper
• A Comparatively Study of Machine Learning Approaches to Predict Service of Disease Haemophilia A

  2021cites this paper
• Novel Severe Hemophilia A Mouse Model with Factor VIII Intron 22 Inversion

  2021cites this paper
• A new paradigm for personalized prophylaxis for patients with severe haemophilia A

  2020cites this paper
• Mutation analysis in the F8 gene in 485 families with haemophilia A and prenatal diagnosis in China

  2020cites this paper
• Innovative Therapeutic and Delivery Approaches Using Nanotechnology to Correct Splicing Defects Underlying Disease

  2020cites this paper
• Bleeder With a Clot: Thrombosis Following Treatment of Bleeding in a Child With Severe Hemophilia B.

  2020cites this paper
• Transitioning of Care from Pediatric to Adult Providers Among Hemophilia Patients

  2020cites this paper
• Genetic analysis for carrier diagnosis in hemophilia A and B in the Mexican population: 25 years of experience

  2020influential citation
• Molecular genetic diagnosis by next-generation sequencing in a cohort of Mexican patients with haemophilia and report of novel variants.

  2020cites this paper
• Qualitative Disorders

  2020cites this paper
• Current trends of Hepatitis C virus genotypes and associated risk factors in hemophilia patients in Pakistan.

  2020cites this paper
• Origins, Development, Current Challenges and Future Directions with Activated Prothrombin Complex Concentrate for the Treatment of Patients with Congenital Haemophilia with Inhibitors

  2020cites this paper
• Identification of Key Coagulation Activity Determining Elements in Canine Factor VIII

  2020cites this paper
• The challenge of genetically unresolved haemophilia A patients: Interest of the combination of whole F8 gene sequencing and functional assays

  2020cites this paper
• Hemofilia B o enfermedad de Christmas

  2020cites this paper
• Magnetic Levitation Systems for Disease Diagnostics.

  2020cites this paper
• F8 Gene

  2020cites this paper
• Common Genetic Variants in ABO and CLEC4M Modulate the Pharmacokinetics of Recombinant FVIII in Severe Hemophilia A Patients

  2020cites this paper
• Factor VIII Intron 22 Inversion in Severe Hemophilia A Patients in Palestine

  2020cites this paper
• Molecular Techniques for Prenatal Diagnosis

  2019cites this paper
• Detection of intron 22 inversion type I and II of factor VIII gene in female carriers of hemophilia a using Inverse shifting PCR (IS-PCR) method

  2019cites this paper
• Application of Indirect Linkage Analysis for Carrier Detection of Hemophilia A in Kurdistan Region of Iraq: Usefulness of Intron 18 BclI T>A, Intron 19 HindIII C>T, and IVS7 nt27 G>A Markers

  2019cites this paper
• Genotype-Phenotype Heterogeneity in Haemophilia

  2019cites this paper
• Era of Genomic Medicine: A Narrative Review on CRISPR Technology as a Potential Therapeutic Tool for Human Diseases

  2019cites this paper
• High resolution melting for F9 gene mutation analysis in patients with haemophilia B.

  2019cites this paper
• Phenotypic characterization of haemophilia B – Understanding the underlying biology of coagulation factor IX

  2019cites this paper
• Caracterización Molecular del gen F9 y correlación genotipo-fenotipo en una muestra de pacientes con hemofilia B en Colombia

  2019cites this paper
• Splicing dysregulation contributes to the pathogenicity of several F9 exonic point variants

  2019cites this paper
• Менеджмент наследственных нарушений свертываемости крови во время беременности

  2018cites this paper
• Mutational Profiles of F8 and F9 in a Cohort of Haemophilia A and Haemophilia B Patients in the Multi-ethnic Malaysian Population

  2018influential citation
• Evolving Complexity in Hemophilia Management.

  2018cites this paper
• Drug-Abuse Nanotechnology: Opportunities and Challenges.

  2018cites this paper
• Variants in FIX propeptide associated with vitamin K antagonist hypersensitivity: functional analysis and additional data confirming the common founder mutations

  2018cites this paper
• Individual thrombin generation and spontaneous bleeding rate during personalized prophylaxis with Nuwiq® (human‐cl rhFVIII) in previously treated patients with severe haemophilia A

  2018cites this paper
• Risk factors for inhibitor development in severe hemophilia a.

  2018cites this paper
• Genetics of Hypercoagulable and Hypocoagulable States.

  2018cites this paper
• When sex matters: a complete model of X-linked diseases

  2018cites this paper
• Interested in publishing with us ? Contact book

  2018cites this paper
• Platelet disorders is common cause of bleeding manifestation pediatrics age group –study at tertiary heath care center CNBC & M.Y. Hospital Indore

  2018cites this paper
• Genetic Risk Factors and Inhibitor Development in Hemophilia: What Is Known and Searching for the Unknown

  2018cites this paper
• Perspectives on progressive strategies and recent trends in the production of recombinant human factor VIII.

  2018cites this paper
• Use of two complementary new molecular techniques, next‐generation sequencing and droplet digital PCR, for diagnosis of an F8 gene deletion and subsequent carrier analysis in a family with haemophilia A: A Case Report

  2018cites this paper
• Modelling and stability analysis in human population genetics with selection and mutation

  2018cites this paper
• Effect of propeptide amino acid substitution in γ‐carboxylation, activity and expression of recombinant human coagulation factor IX

  2018cites this paper
• A discrete time population genetic model for X-linked recessive diseases

  2017cites this paper
• Screening of Intron 1 Inversion of the Factor VIII Gene in 130 Patients with Severe Hemophilia A from a Pakistani Cohort

  2017cites this paper
• Molecular Analysis of Factor VIII and Factor IX Genes in Hemophilia Patients: Identification of Novel Mutations and Molecular Dynamics Studies

  2017cites this paper
• Management of Inherited Bleeding Disorders in Pregnancy

  2017cites this paper
• Factor IX Gene (F9) Genotyping Trends and Spectrum of Mutations Identified: A Reference Laboratory Experience

  2017cites this paper
• Noninvasive detection of F8 int22h-related inversions and sequence variants in maternal plasma of hemophilia carriers.

  2017cites this paper
• CLINICAL PROFILE OF HAEMOPHILIA IN CHILDREN IN A TERTIARY CARE CENTRE

  2017cites this paper
• Genetic Correction and Hepatic Differentiation of Hemophilia B-specific Human Induced Pluripotent Stem Cells.

  2017cites this paper
• Physiotherapy Treatments in Musculoskeletal Pathologies Associated with Haemophilia

  2017cites this paper
• A de novo factor VIII mutation in a haemophilia B family leading to combined deficiency of factor VIII and IX

  2017cites this paper
• Recent Progress in Biopharmaceutical Drugs Research and Development

  2017cites this paper
• Molecular genetic study of hemophilia B in an Algerian population

  2016cites this paper
• New developments in the management of moderate-to-severe hemophilia B

  2016cites this paper
• Nonsense-mediated mRNA decay among coagulation factor genes

  2016cites this paper
• Congenital Coagulation Disorders

  2016cites this paper
• Effects of selection and mutation on epidemiology of X-linked genetic diseases.

  2016cites this paper
• Mutation analysis of Swedish haemophilia B families – high frequency of unique mutations

  2016cites this paper
• Violating the Theory of Single Gene-Single Disorder: Inhibitor Development in Hemophilia

  2015cites this paper
• Human coagulation factor VIII domain-specific recombinant polypeptide expression

  2015cites this paper
• Hemophilia A in a Senior Patient: A Case Report of Spinal Epidural Hematoma as First Presentation

  2015cites this paper
• Practice Guidelines for the Molecular Diagnosis of Haemophilia A

  2015cites this paper
• Molecular characterization of ten F8 splicing mutations in RNA isolated from patient's leucocytes: assessment of in silico prediction tools accuracy

  2015cites this paper
• Stability and sensitivity analysis of an epidemiological model of genetic diseases

  2015cites this paper
• Alloantibodies to therapeutic factor VIII in hemophilia A: the role of von Willebrand factor in regulating factor VIII immunogenicity

  2015cites this paper
• Coagulation factor VII variants resistant to inhibitory antibodies

  2014cites this paper
• A Novel Missense Mutation, E1623G, in the Human Factor VIII Gene Associated With Moderate Haemophilia A

  2014cites this paper
• Factor IX mutations in hemophilia B patients from Liaoning Province, China

  2014cites this paper
• Hemophilia B—Molecular Basis

  2014cites this paper
• Non linear discrete time epidemiological model for X-linked recessive diseases

  2014cites this paper
• Coagulopathy After Severe Pediatric Trauma

  2014cites this paper
• Factor VIII genetic mutations and protein alterations in hemophilia A: A review

  2014cites this paper
• Identification and Genetic Analysis of a Factor IX Gene Intron 3 Mutation in a Hemophilia B Pedigree in China

  2014cites this paper